Wall Street Zen Downgrades Uranium Royalty (NASDAQ:UROY) to Hold
by Renee Jackson · The Cerbat GemUranium Royalty (NASDAQ:UROY – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday.
Several other research analysts also recently commented on UROY. Weiss Ratings upgraded Uranium Royalty from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, March 12th. Raymond James Financial restated a “market perform” rating on shares of Uranium Royalty in a report on Wednesday, January 14th. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $4.50.
View Our Latest Research Report on Uranium Royalty
Uranium Royalty Stock Performance
UROY stock opened at $3.63 on Friday. Uranium Royalty has a 52 week low of $1.65 and a 52 week high of $5.52. The firm’s fifty day moving average is $3.84 and its 200 day moving average is $3.96. The firm has a market cap of $531.72 million, a P/E ratio of 181.59 and a beta of 1.50.
Uranium Royalty (NASDAQ:UROY – Get Free Report) last issued its earnings results on Tuesday, March 10th. The company reported $0.01 EPS for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.02. Uranium Royalty had a net margin of 7.70% and a return on equity of 0.01%. The company had revenue of $12.25 million for the quarter. As a group, analysts forecast that Uranium Royalty will post 0.01 EPS for the current year.
Institutional Investors Weigh In On Uranium Royalty
Large investors have recently added to or reduced their stakes in the company. Goldman Sachs Group Inc. increased its position in shares of Uranium Royalty by 25.4% in the first quarter. Goldman Sachs Group Inc. now owns 104,243 shares of the company’s stock valued at $183,000 after acquiring an additional 21,118 shares during the period. Thompson Davis & CO. Inc. purchased a new stake in shares of Uranium Royalty during the second quarter worth about $33,000. Vident Advisory LLC grew its stake in shares of Uranium Royalty by 47.1% in the second quarter. Vident Advisory LLC now owns 1,480,151 shares of the company’s stock worth $3,700,000 after purchasing an additional 474,030 shares during the last quarter. Corient Private Wealth LLC bought a new stake in shares of Uranium Royalty in the second quarter worth about $29,000. Finally, Accordant Advisory Group Inc increased its holdings in Uranium Royalty by 0.4% during the 3rd quarter. Accordant Advisory Group Inc now owns 2,450,607 shares of the company’s stock valued at $10,538,000 after purchasing an additional 8,905 shares during the period. Institutional investors own 24.19% of the company’s stock.
Uranium Royalty Company Profile
Uranium Royalty Corp. is a Vancouver-based mineral rights acquisition, royalty and streaming company focused exclusively on the uranium sector. Established in early 2021 and listed on the NASDAQ under the symbol UROY, the company seeks to provide investors with leveraged exposure to uranium prices without direct mining risk. Rather than owning or operating mines, Uranium Royalty acquires long-term royalties and streams on both production and development-stage uranium projects worldwide.
The company’s diversified portfolio encompasses royalty interests across multiple jurisdictions, including Canada, the United States, South America, Central Asia and Australia.